Home
Conditions
Gastrointestinal Neoplasms

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,331 public trials 2,090 recruiting studies

Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Effect of CCRT on Respiratory Performance and Functional Capacity in Esophagus Cancer Patients

NCT01766349

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +7 more
Locations: Far Eastern Memorial hospital New Taipei City, Taiwan

View Trial Details

Completed

BIBF 1120 Versus Bevacizumab in Metastatic Colorectal Cancer

NCT00904839

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
Locations: 1199.51.32002 Boehringer Ingelheim Investigational Site Bonheiden, Belgium

1199.51.32005 Boehringer Ingelheim Investigational Site Brussels, Belgium

1199.51.32006 Boehringer Ingelheim Investigational Site Brussels, Belgium

1199.51.32001 Boehringer Ingelheim Investigational Site Leuven, Belgium

View all 47 locations

View Trial Details

Completed

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer

NCT00673673

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations: Medical Oncology & Hematology PC Hamden, Connecticut, United States

Yale University School of Medicine New Haven, Connecticut, United States

View Trial Details

Completed

An RCT for the Effect of Biofeedback Therapy the Prevention of AR Syndrome in Rectal Cancer Patients

NCT01661829

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Division of Colorectal Disease, Department of Surgery, St. Vincent's Hospital, The Catholic University of Korea Suwon, South Korea

View Trial Details

Completed

Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor

NCT01267695

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations: Peking University School of Oncology Beijing, China

View Trial Details

Completed

A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer

NCT01269216

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Completed

Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins

NCT02348229

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: Not specified

View Trial Details

Completed

Comparison of O-type Hybrid Knife and IT Knife in ESD

NCT01760070

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +12 more
Locations: Xijing Hospital of Digestive Diseases Xi'an, Shaanxi, China

View Trial Details

Completed

FLOX + Cetuximab (Erbitux®) for Patients With Metastatic Colorectal Cancer and Wild Type K-RAS Tumor

NCT00660582

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Department of Oncology, Aalborg University Hospital Aalborg, Denmark

Department of Oncology, Herlev University Hospital Herlev, Denmark

Department of Oncology, Odense University Hospital Odense, Denmark

Department of Oncology, Haukeland University Hospital Bergen, Norway

View Trial Details

Completed

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

NCT01874938

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations: For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea

View Trial Details

Gastrointestinal Neoplasms

Gastrointestinal Neoplasms trial results

Related conditions